Alternatives to Phenoxybenzamine If You Can't Fill Your Prescription

Phenoxybenzamine (Dibenzyline) is the only FDA-approved alpha-adrenergic blocker specifically indicated for pheochromocytoma, but it is far from the only option your doctor has available. When phenoxybenzamine is unavailable, unaffordable, or poorly tolerated, several alternative medications can be used — and clinical evidence shows that most patients do just as well with them.

This article explains the most commonly used alternatives and what the research says about how they compare. Always work with your prescribing physician before making any changes to your treatment plan.

Why Alternatives Are Commonly Used

Phenoxybenzamine is the traditional first choice for pheochromocytoma preoperative preparation because of its irreversible, long-lasting blockade of alpha receptors. This is particularly valuable during surgery, when tumor manipulation can release a sudden surge of catecholamines. The covalent bond phenoxybenzamine forms with alpha receptors cannot be overcome by a bolus of adrenaline, which is why many anesthesiologists and endocrine surgeons still prefer it.

However, phenoxybenzamine costs up to 100 times more than alternatives like doxazosin, is rarely stocked at retail pharmacies, and causes more side effects (especially orthostatic hypotension and nasal congestion) than selective alpha-1 blockers. Many centers worldwide have shifted to selective alpha-1 blockers as their primary agents, and clinical trials have not shown a meaningful difference in patient outcomes.

Doxazosin (Cardura) — Most Common Alternative

Doxazosin is a selective, competitive alpha-1 adrenergic blocker. Unlike phenoxybenzamine, it does not bind irreversibly to receptors — it competes with catecholamines for the binding site. This makes it easier to titrate and leads to less postoperative hypotension.

The first randomized controlled trial directly comparing phenoxybenzamine and doxazosin (the PRESCRIPT trial) found no significant difference in the primary endpoint between the two drugs for pheochromocytoma surgery outcomes. Phenoxybenzamine showed slightly better intraoperative hemodynamic stability, but this did not translate into a difference in cardiovascular complications.

Doxazosin is available at virtually every retail pharmacy and costs a fraction of phenoxybenzamine's price. It is dosed once daily, starting at 1 mg and titrated up to 8-16 mg as needed. It does not typically cause reflex tachycardia or nasal congestion.

Prazosin (Minipress) — Shorter-Acting Selective Option

Prazosin was one of the earliest selective alpha-1 blockers used for pheochromocytoma management. It has a shorter half-life than doxazosin, requiring two to three doses per day, but this also makes it more flexible for titration. Several studies have found comparable hemodynamic outcomes between prazosin and phenoxybenzamine.

Prazosin is widely available at standard retail pharmacies and is inexpensive in generic form. Dosing typically starts at 1 mg twice or three times daily and is titrated upward. Orthostatic hypotension can be significant, particularly after the first dose, so patients are advised to take their first dose at bedtime.

Terazosin (Hytrin) — Once-Daily Convenience

Terazosin is another selective alpha-1 blocker used off-label for pheochromocytoma preparation. It has a longer half-life than prazosin, allowing once-daily dosing in many patients. Dosing typically ranges from 2 to 10 mg per day. It is widely available at retail pharmacies and is generally well tolerated.

Metyrosine (Demser) — Adjunct Therapy, Not a Substitute

Metyrosine works through a completely different mechanism: it inhibits tyrosine hydroxylase, the enzyme that initiates catecholamine synthesis, reducing the amount of adrenaline and noradrenaline your body produces. It is not used as a standalone replacement for phenoxybenzamine but has been shown to improve intraoperative hemodynamic stability when added to either phenoxybenzamine or a selective alpha-1 blocker.

Metyrosine can cause significant central nervous system side effects including sedation, depression, and extrapyramidal symptoms. It is typically reserved for patients with refractory hypertension or large, catecholamine-secreting tumors.

Calcium Channel Blockers — An Alternative Approach

Calcium channel blockers (CCBs) such as nicardipine, amlodipine, and nifedipine are sometimes used either as adjuncts to alpha-blockers or, in select cases, as primary preoperative agents. They block calcium influx in vascular smooth muscle, preventing catecholamine-mediated vasoconstriction. CCBs are widely available, well-tolerated, and do not cause reflex tachycardia.

Multiple studies have shown that CCBs produce similar intraoperative hemodynamic stability compared with alpha-blockers, particularly for smaller or less-active tumors. They are often added to alpha-blocker therapy when blood pressure control is inadequate.

How Do You Choose the Right Alternative?

The choice of alternative depends on your tumor characteristics, blood pressure levels, tolerance, and your surgeon's preference. As a general framework:

Moderate blood pressure elevation: doxazosin or prazosin are first-line alternatives

Refractory hypertension or large tumors: consider adding metyrosine or a CCB to an alpha-blocker

Intolerance to orthostatic hypotension: selective alpha-1 blockers cause less postoperative hypotension than phenoxybenzamine

Cost or availability concern: doxazosin is 100x less expensive than phenoxybenzamine and available at every pharmacy

Getting the Right Help

If your physician decides to keep you on phenoxybenzamine, you still need to find a pharmacy that stocks it. medfinder calls pharmacies near you to check availability and texts you results — so you spend less time on hold and more time focused on your health. For more strategies on locating phenoxybenzamine, see our guide:

How to Find Phenoxybenzamine In Stock Near You (Tools + Tips for 2026).